ストックスクリーナーアプリを入手
143.13
2.14%
3.00
アフターアワーズ：
143.13
Insmed Inc (INSM) 最新ニュース
Victory Capital Management Inc. Boosts Position in Insmed, Inc. $INSM - MarketBeat
Is Insmed Incorporated stock a safe investment in uncertain marketsInsider Selling & Free Technical Pattern Based Buy Signals - Naître et grandir
Insmed Incorporated (INSM) Price Target Raised to $211 at BofA - Finviz
Institution Moves: What are the future prospects of Insmed IncorporatedBear Alert & Accurate Buy Signal Alerts - baoquankhu1.vn
William Lewis Sells 10,699 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
Insmed Breaks Below 200-Day Moving AverageNotable for INSM - Nasdaq
Insmed Grants Inducement Awards to 85 New Employees - Intellectia AI
GW&K Investment Management LLC Sells 672,513 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed hands 85 new employees stock units and long-term options - Stock Titan
Picton Mahoney Asset Management Sells 34,001 Shares of Insmed, Inc. $INSM - MarketBeat
INSM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pulmonary Arterial Hypertension Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma, Keros Therap - Barchart.com
Is It Time To Reassess Insmed (INSM) After A 92% One Year Surge? - Yahoo Finance
Insmed, Inc. $INSM Shares Sold by Rafferty Asset Management LLC - MarketBeat
10 Stocks That Could Skyrocket in 2026 - Insider Monkey
Insmed’s BRINSUPRI Outperformance Puts Commercial Execution And Valuation In Focus - simplywall.st
Insmed Incorporated (INSM): Investor Outlook Reveals A Promising 42% Upside - DirectorsTalk Interviews
Assessing Insmed (INSM) Valuation After Recent Share Price Weakness And Brensocatib Launch Expectations - Yahoo Finance
Insmed at TD Cowen Conference: Strategic Growth and Market Expansion - Investing.com South Africa
INSM: Strong Q4 launch, expanding access, and promising pipeline set stage for significant growth - TradingView
HC Wainwright Has Negative Outlook of Insmed FY2026 Earnings - MarketBeat
William Blair Investment Management LLC Has $223.94 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated (INSM) Enters 2026 With Momentum - Finviz
10 Unstoppable Stocks to Buy and Hold for the Next 3 Years - Insider Monkey
Insmed (INSM) director gifts shares and details family holdings - Stock Titan
Insmed, Inc. Experiences Revision in Its Stock Evaluation Amid Financial Performance Trends - Markets Mojo
Artisan Partners Limited Partnership Grows Stock Position in Insmed, Inc. $INSM - MarketBeat
Why Insmed (INSM) Is Down 6.8% After Wider 2025 Losses But Rapid Brinsupri Launch Traction - simplywall.st
Why Insmed Incorporated (INSM) is One of the Best Strong Buy Healthcare Stocks to Invest In - Finviz
Westfield Capital Management Co. LP Lowers Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Thornburg Investment Management Inc. Trims Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Stock Hits Day Low of $148.24 Amid Price Pressure - Markets Mojo
INSMED Chief Legal Officer Sells Shares Worth Over $3.8 Million - TradingView
Insmed (INSM) CLO exercises options and sells 24,774 shares - Stock Titan
Director David R. Brennan gifts 6,000 INSM (NASDAQ: INSM) shares in Form 4 - Stock Titan
United unveils newly partnered soft mist inhaler; Mannkind sinks - bioworld.com
Insmed (INSM) Q4 2025 Earnings Call Transcript - AOL.com
HC Wainwright Forecasts Insmed's Q3 Earnings (NASDAQ:INSM) - MarketBeat
Brown Advisory Small-Cap Growth Fund's Insmed Inc(INSM) Holding History - GuruFocus
INSM (NASDAQ: INSM) reports Michael Smith sales and issuer plan issuances - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: Travere Therapeutics (TVTX), Insmed (INSM) - The Globe and Mail
H.C. Wainwright Remains a Buy on Insmed (INSM) - The Globe and Mail
INSM Stock Rating: Mizuho Lowers Price Target Amid Consistent Ou - GuruFocus
Mizuho Issues Pessimistic Forecast for Insmed (NASDAQ:INSM) Stock Price - MarketBeat
Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE - Yahoo Finance
HC Wainwright Comments on Insmed's Q1 Earnings (NASDAQ:INSM) - MarketBeat
Insmed chair and CEO Lewis sells $1.6m in stock By Investing.com - Investing.com Nigeria
Insmed chair and CEO Lewis sells $1.6m in stock - Investing.com
Insmed (INSM) Is Up 6.9% After BRINSUPRI Sales Beat Expectations And 2026 Target SetWhat's Changed - Yahoo Finance
H.C. Wainwright reiterates Buy on Insmed stock, $230 target By Investing.com - Investing.com UK
Insmed (INSM) CEO Lewis exercises options and sells 10,699 shares - Stock Titan
INSM: HC Wainwright & Co. Reiterates Buy Rating with $230 PT | I - GuruFocus
Mizuho Securities Cuts Insmed Price Target to $204 From $211, Maintains Outperform Rating - marketscreener.com
Insmed (NASDAQ:INSM) Given Buy Rating at HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy on Insmed stock, $230 target - Investing.com
Patient Square Capital LP Reduces Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Gets UK Marketing Authorization for Non-Cystic Fibrosis Bronchiectasis Treatment - marketscreener.com
Hillsdale Investment Management Inc. Sells 7,000 Shares of Insmed, Inc. $INSM - MarketBeat
Bank of America Securities Reaffirms Their Buy Rating on Insmed (INSM) - The Globe and Mail
0.39%
大文字化:
|
ボリューム (24 時間):